ARK Invest's position in PACB, updated every trading day. Data as of 2026-11-12.
| Fund | Shares | Value | Weight | Rank |
|---|---|---|---|---|
| ARKK | 18,359,617 | $36.2M | 0.50% | #40 |
| ARKG | 12,472,499 | $24.6M | 1.24% | #27 |
| Trade day | Fund | Side | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-11-04 | ARKK | Buy | Added | 54,040 | $138K |
| 2026-11-04 | ARKG | Buy | Added | 19,241 | $49K |
| 2026-11-03 | ARKK | Buy | Added | 187,449 | $457K |
| 2026-11-03 | ARKG | Buy | Added | 67,004 | $163K |
| 2026-11-02 | ARKK | Buy | Added | 455,471 | $1.1M |
| 2026-11-02 | ARKG | Buy | Added | 164,417 | $386K |
| 2026-10-30 | ARKK | Buy | Added | 346,507 | $903K |
| 2026-10-30 | ARKG | Buy | Added | 133,767 | $348K |
| 2026-10-26 | ARKK | Buy | Added | 28,159 | $63K |
| 2026-10-26 | ARKG | Buy | Added | 11,291 | $25K |
| 2026-10-23 | ARKK | Buy | Added | 202,427 | $427K |
| 2026-10-23 | ARKG | Buy | Added | 68,266 | $144K |
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing solutions to resolve genetically complex problems. The company provides sequencing systems; consumable products, including single molecule real-time (SMRT) technology; long-read sequencing; and various reagent kits designed for specific workflow, such as preparation kit to convert DNA into SMRTbell double-stranded DNA library…
See PACB's full ARK history since 2024, ARK's estimated cost basis, the conviction score and buy/sell alerts.
Open PACB on FundWake →Data comes from ARK Invest's public daily holdings and trade files. FundWake is not affiliated with ARK Invest. Nothing here is investment advice.